Pfizer Will Re-Brand Viagra As Revatio For Pulmonary Arterial Hypertension
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer submits sildenafil for pulmonary arterial hypertension under Revatio trademark; firm also plans to differentiate the PAH indication from the Viagra brand with different color and shape tablets. Pfizer is requesting priority review for the NDA, submitted Dec. 2